SHOWNOTES

[00:00:00] Introduction

[00:00:57] Exhibit C: World Oil Supply/Demand

Hunt discusses Israel's recent actions and their impact on oil facilities.

Analysis of OPEC's plan to increase oil supply by one million barrels per day starting December.

Suggestion to monitor oil company stocks for potential investment opportunities.

[00:02:47] Exhibit B: U.S. Gas Demand/Supply

Examination of gas demand growth and LNG exports.

Discussion on renewable energy's impact on gas demand for power generation.

Projections for gas prices in 2024 and 2025.

Mention of increased gas imports from Canada.

[00:05:53] Exhibit A: U.S. Government Revenues and Expenses

Review of the U.S. government's cash flow and spending challenges.

Analysis of major expense categories: Social Security, Medicare, Medicaid, interest, and defense.

Discussion on the difficulty of reducing government spending by $2 trillion.

Emphasis on the need to flatline spending and promote economic growth.

[00:08:24] AI's Impact on the Election Cycle

Jason notes that fears about AI-generated misinformation did not materialize significantly.

Discussion on deep fakes and the role of tech companies in suppressing misinformation.

Mike cautions that the election is not over yet.

[00:09:20] Analyzing the Netflix Franchise

Hunt challenges Mike and Jason to analyze Netflix's position in the streaming industry.

Comparison between Netflix, Spotify, and YouTube.

Jason predicts a potential duopoly between Netflix and YouTube.

Mike discusses different content types and their value, such as live sports vs. reusable shows.

Analysis of competitive dynamics and market strategies of streaming services.

[00:16:42] Franchise Values of Google, Microsoft, and Their Challengers

Hunt questions the strength of Google's search franchise amid AI advancements.

Jason and Mike discuss Bing's market share and the potential for AI to disrupt traditional search.

Conversation about OpenAI, ChatGPT, and Google's AI capabilities.

Speculation on Meta's influence by giving away AI products.

[00:23:54] Healthcare Update: Lilly Earnings and Vertex Pharmaceuticals

Hunt introduces the healthcare segment focusing on Eli Lilly and Vertex Pharmaceuticals.

Jason explains Lilly's earnings miss due to compounding pharmacies affecting sales.

Discussion on FDA regulations and the legal battle with compounding pharmacies.

Update on Vertex's pain drug, market size, and potential to reduce opioid addiction.

Mention of CVS considering a breakup and antitrust actions against PBMs (Pharmacy Benefit Managers).

Brief discussion on UnitedHealth's financial performance.

[00:31:13] Closing Remarks

$NFLX $GOOGL $MSFT $SPOT $META $AMZN $LLY $VRTX $UNH $CVS

This podcast and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com